Helex raises $3.5 Mn in seed round led by pi Ventures

October 30, 2025

Share via:

Helex, a therapeutics startup developing a new class of targeted medicines for genetic kidney diseases, has raised $3.5 million in a seed funding round led by pi Ventures, along with participation from Bluehill Capital, SOSV, and a global syndicate of investors.

With this round, Helex has raised over $6 million in total funding to date. The proceeds will be used to accelerate its lead candidate for Autosomal Dominant Polycystic Kidney Disease (ADPKD) while advancing its platform to establish a differentiated kidney therapeutics portfolio, Helex said…

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

Previous News

A New Startup Wants to Edit Human Embryos

Next News

How to avail free Google AI Pro subscription for Reliance Jio users? Check step-by-step guide

Popular

More Like this

Helex raises $3.5 Mn in seed round led by pi Ventures

October 30, 2025

, Published By Entracker

Helex, a therapeutics startup developing a new class of targeted medicines for genetic kidney diseases, has raised $3.5 million in a seed funding round led by pi Ventures, along with participation from Bluehill Capital, SOSV, and a global syndicate of investors.

With this round, Helex has raised over $6 million in total funding to date. The proceeds will be used to accelerate its lead candidate for Autosomal Dominant Polycystic Kidney Disease (ADPKD) while advancing its platform to establish a differentiated kidney therapeutics portfolio, Helex said…

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

Website Upgradation is going on for any glitch kindly connect at office@startupnews.fyi

Previous News

A New Startup Wants to Edit Human Embryos

Next News

How to avail free Google AI Pro subscription for Reliance Jio users? Check step-by-step guide

More like this

Popular

Block title